Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00747682 · ClinicalTrials.gov registry record
Cerebral Perfusion, Oxygenation, Electrical Activity
A clinical trial of Post-Hemorrhagic Hydrocephalus, sponsored by University of Utah.
- Completed
- Registry status
- 30
- Enrollment target
- 1
- Study location
NCT00747682: Completed study of Post-Hemorrhagic Hydrocephalus, sponsored by University of Utah.
NCT00747682 is a study of Post-Hemorrhagic Hydrocephalus that has completed, run by University of Utah. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00747682, a study of Post-Hemorrhagic Hydrocephalus, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
The specific aim of the research proposal in preterm infants with IVH and PHH who require placement of an Omaya reservoir or a shunt is to determine if decreasing ventricular volume improves, middle cerebral artery flow, cerebral oxygenation, and cortical neuronal electrical activity. To accomplish this aim, we will simultaneously perform the following evaluations prior to shunt placement or prior to and after routine CSF aspiration from reservoir in: 1. middle cerebral artery velocity time integral and resistive index using Doppler ultrasonography 2. cerebral oxygenation using near infrared spectroscopy (NIRS) 3. background neuronal electrical activity using an EEG. In addition, we will measure serial CSF concentration of neuroproteins, S100B, GFAP, NSE, TGF-ß, and IL-6, as evidence of ongoing neuronal damage and correlate the concentration with cerebral perfusion and activity as measured above.
Conditions Studied
Study Locations (1)
Utah
- University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-07 |
| Est. Completion | 2009-08 |
What the finished NCT00747682 record still lists
NCT00747682 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 1 condition, with Post-Hemorrhagic Hydrocephalus appearing as the primary indexed condition, and to 0 interventions.
NCT00747682 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT00747682 about?
NCT00747682 is a clinical study titled "Cerebral Perfusion, Oxygenation, Electrical Activity". The specific aim of the research proposal in preterm infants with IVH and PHH who require placement of an Omaya reservoir or a shunt is to determine if decreasing ventricular volume improves, middle cerebral artery flow, cerebral oxygenation, and cortical neuronal electrical activity. To accomplish ...
What is the current status of trial NCT00747682?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2006-07. Estimated completion is 2009-08.
What conditions does trial NCT00747682 study?
This clinical trial studies the following conditions: Post-Hemorrhagic Hydrocephalus.
Who is sponsoring clinical trial NCT00747682?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00747682 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia